Annual report
4584.TEDINET S100R99R
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 12 passed
Amended by S100RRF2 (2023-08-25). Amended by S100TKR2 (2024-06-07).
Key figures · 97
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.8bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥997m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥967m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥964m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥551m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥651m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥625m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥969m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥953m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥991m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥956m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.2bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥816m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥656m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥550m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income (owners) | −¥535m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥7.3bn | 2019-04-01 → 2020-03-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥657m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥551m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥7.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥856m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2022-03-31 | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.7bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-03-31 | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.7bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-03-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.0bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.0bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥860m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥29m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥527m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥22m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥137m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27,000 | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥369m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥718m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥978m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-20.77 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.35 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.86 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-34.79 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-264.65 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-43.84 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥32.36 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥48.79 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥48.3 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥50.44 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥51.73 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥132.55 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 26.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 32,059,713 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,437,547 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 29,622,847 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 27,646,986 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 20,342,446 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 41 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 38 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 45 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 29 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 26 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 859
| Item | Context | Value | Unit |
|---|---|---|---|
| Contract assets | CurrentYearInstant_NonConsolidatedMember | 52550000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 903062000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 1216349000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-30 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第23期（自 2022年４月１日 至 2023年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)キッズウェル・バイオ株式会社 | |
| Company name in english cover page | FilingDateInstant | Kidswell Bio Corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 紅林 伸也 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区新川一丁目２番12号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6222-9547（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)社長室長 栗原 隆浩 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区新川一丁目２番12号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-6222-9547（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)社長室長 栗原 隆浩 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E27032 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45840 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)キッズウェル・バイオ株式会社 | |
| Filer name in english | FilingDateInstant | Kidswell Bio Corporation | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | mismatch |
| statement vs summary · total assets | pass |